Capcom Boston Consulting Group Matrix
Fully Editable
Tailor To Your Needs In Excel Or Sheets
Professional Design
Trusted, Industry-Standard Templates
Pre-Built
For Quick And Efficient Use
No Expertise Is Needed
Easy To Follow
Capcom Bundle
What is included in the product
Detailed Word Document
Tailored analysis for Capcom's product portfolio in the BCG Matrix
Customizable Excel Spreadsheet
Printable summary optimized for A4 and mobile PDFs, making strategic insights accessible anywhere.
Full Transparency, Always
Capcom BCG Matrix
The preview shows the complete Capcom BCG Matrix you'll receive after purchase. This ready-to-use, professionally designed document offers strategic insights and visual clarity. Get immediate access to the full report – no hidden content or further steps. It is designed for seamless integration into your business analysis and presentations.
BCG Matrix Template
Actionable Strategy Starts Here
Capcom's BCG Matrix offers a snapshot of its diverse portfolio. It categorizes games like "Monster Hunter" and "Street Fighter" to assess their market position. The matrix reveals potential "Stars," "Cash Cows," "Dogs," and "Question Marks" within Capcom's offerings. Understand the growth prospects and resource needs of each game. Unlock a comprehensive strategy with the full BCG Matrix—purchase now for actionable insights!
Stars
Resident Evil Series
The Resident Evil series is a "Star" in Capcom's BCG matrix. The franchise's recent games, like Resident Evil 4 Remake, have sold millions. Resident Evil's strong sales and fan base ensure its position. The series is a significant revenue generator for Capcom.
Monster Hunter Series
The Monster Hunter series is a 'Star' in Capcom's portfolio, showing significant growth. The franchise has sold over 100 million units globally as of December 2023. Monster Hunter Wilds, slated for early 2025, aims to continue this momentum. Its innovative features and global appeal solidify its 'Star' status.
Street Fighter 6
Street Fighter 6, launched in 2023, has become a shining 'Star'. The game sold over 3 million copies by the end of 2023, showing strong market performance. Its popularity in esports and consistent updates with new content have sustained its success. This is a clear win for Capcom.
Dragon's Dogma 2
Dragon's Dogma 2, launched in March 2024, has become a 'Star' for Capcom due to its impressive sales. The game's open-world RPG gameplay and positive reviews have driven its rapid commercial success. Capcom reported that the game sold over 2.5 million units in its launch week. This strong performance positions Dragon's Dogma 2 as a key growth driver.
- Release Date: March 2024
- Units Sold (Launch Week): Over 2.5 million
- Category: Rising 'Star' in Capcom's portfolio
- Impact: Significant revenue and growth potential
Digital Sales Strategy
Capcom's digital sales strategy is a key factor in its success, especially for its "Star" franchises. Digital distribution expands its reach, driving revenue growth. In FY2024, digital sales represented a significant portion of total sales, around 80%. This strategy supports all major franchises, fueling their stellar performance.
- Digital sales contribute significantly to total revenue.
- Expansion of digital distribution channels.
- Stable revenue from catalog titles.
- Supports the performance of all major franchises.
Capcom's Stellar Sales: Digital Dominance & Franchise Strength
Capcom's "Star" franchises are consistently strong revenue drivers, with Dragon's Dogma 2 exceeding 2.5 million sales in its first week. Digital sales play a crucial role, representing approximately 80% of FY2024's total sales. These factors highlight the ongoing success.
| Franchise | Sales (Units) | Digital Sales (%) |
|---|---|---|
| Resident Evil | Millions | 80% |
| Monster Hunter | 100M+ (Global) | 80% |
| Street Fighter 6 | 3M+ (2023) | 80% |
| Dragon's Dogma 2 | 2.5M+ (Launch week) | 80% |
Cash Cows
Monster Hunter: World
Monster Hunter: World, despite newer titles being 'Stars,' is a 'Cash Cow' for Capcom. It has sold over 28 million copies, generating consistent revenue. The game's presence on various platforms sustains its strong financial performance. This enduring popularity solidifies its status as a reliable income source.
Resident Evil 7: Biohazard
Resident Evil 7: Biohazard is a reliable 'Cash Cow' for Capcom, consistently generating revenue. The game's strong sales and positive reception since its 2017 release, with over 13 million units sold by September 2024, solidify its status. Its innovative gameplay and brand appeal drive continued success. This ensures ongoing financial returns for Capcom.
Resident Evil 2 Remake
Resident Evil 2 Remake is a significant cash cow for Capcom. The game sold over 13.9 million copies as of December 2023. Its consistent sales and positive reviews ensure a steady revenue stream. This remake leverages the established Resident Evil brand, making it highly profitable. The game's success highlights its "Cash Cow" status within the company's portfolio.
Monster Hunter Rise
Monster Hunter Rise remains a cash cow for Capcom, even after the release of newer titles. It has maintained strong sales across multiple platforms, including Nintendo Switch and PC. The game's consistent popularity ensures a steady revenue stream for Capcom. This steady income solidifies its position as a reliable asset.
- Continued sales on Switch and PC platforms.
- Steady revenue generation for Capcom.
- Strong player base support.
Devil May Cry 5
Devil May Cry 5, a key title for Capcom, fits the 'Cash Cow' category. The game has sold over 8.9 million units. Its consistent sales and positive reviews ensure steady revenue. It is a reliable source of income for Capcom.
- Sales: Over 8.9 million units sold.
- Reception: High ratings and positive reviews.
- Revenue: Contributes steadily to Capcom's profits.
- Status: Remains a profitable title.
Top Games Fueling Profits
Capcom's "Cash Cows" are its most profitable and reliable games. These titles, like Resident Evil 2 Remake, consistently generate significant revenue. The sustained success of these games provides a solid financial foundation for the company.
| Game | Units Sold (as of 2024) | Revenue Contribution |
|---|---|---|
| Resident Evil 2 Remake | Over 13.9 million | Steady |
| Monster Hunter: World | Over 28 million | Consistent |
| Devil May Cry 5 | Over 8.9 million | Significant |
Dogs
Dead Rising Series
The "Dead Rising" series, despite a passionate following, hasn't matched the blockbuster success of Capcom's top franchises. Sales figures, such as those from 2024, show it trailing behind giants like "Resident Evil" and "Monster Hunter." With an uncertain future and a smaller market share, the series fits the "Dogs" category. This means limited investment and potential for decline.
Onimusha Series (pre-revival)
Before the Onimusha revival, the series faced dormancy. Its sales lagged behind Capcom's top franchises. This placed it in the "Dog" category. Recent data shows potential, but prior to the revival, its market presence was limited.
Marvel vs. Capcom Series
The Marvel vs. Capcom series is in the "Dogs" category within Capcom's BCG Matrix. Despite a dedicated fanbase, sales haven't always been strong. For example, Marvel vs. Capcom: Infinite, released in 2017, had a mixed reception. Licensing issues and release gaps further complicate its financial performance. Its market share is limited.
Sengoku Basara Series
The Sengoku Basara series, a historical action game, is a "Dog" in Capcom's BCG matrix. Though successful in Japan, it struggles internationally. Its revenue in 2024 was approximately $15 million, a fraction of other Capcom franchises.
- Limited Global Appeal: The series has a niche audience outside Japan.
- Modest Sales: Compared to Resident Evil or Monster Hunter, sales are low.
- Uncertain Future: Capcom hasn't announced new titles recently.
1942 Series
The 1942 series, a relic of arcade history, still has a loyal fanbase. Its financial performance, however, pales against Capcom's giants. This series occupies the "Dogs" quadrant in the BCG Matrix. It has a limited market share and low growth potential.
- Niche appeal limits revenue.
- Low growth prospects.
- Minimal impact on Capcom's overall financials.
- Focus on core franchises is prioritized.
Capcom's "Dogs": Low Sales, Uncertain Future
The "Dogs" in Capcom's portfolio show limited market share and growth. These titles, like "Sengoku Basara" (with ~$15M revenue in 2024), struggle against bigger franchises. Limited investment and an uncertain future define this quadrant, with sales figures trailing behind top performers.
| Franchise | Category | 2024 Revenue (approx.) |
|---|---|---|
| Dead Rising | Dog | Unknown |
| Onimusha | Dog | Revival stage |
| Marvel vs. Capcom | Dog | Mixed, licensing issues |
| Sengoku Basara | Dog | $15 million |
| 1942 | Dog | Minimal |
Question Marks
Kunitsu-Gami: Path of the Goddess
Kunitsu-Gami: Path of the Goddess, a fresh IP, showcases a distinctive art style and gameplay, yet its market performance remains unproven. As a new title, it currently resides in the "Question Mark" quadrant of the Capcom BCG Matrix. Its success hinges on attracting a wide audience and positive reception. Capcom's 2024 financial reports will provide the initial data on this game's performance.
Pragmata
Pragmata, a sci-fi game from Capcom, announced in 2020, has seen delays. The release date is unclear, impacting its market potential. Its uncertain status aligns with the "Question Mark" category. Capcom's 2024 financials will reveal its investment impact. The game's risk-reward profile is high.
Exoprimal
Exoprimal, launched in 2023, presents a novel concept. The game combines dinosaur hunting with exosuit battles. Early reception and sales have been inconsistent. Its future success is still unclear, positioning it as a question mark. The game's sales were around 1 million units in 2023.
Mega Man Series (Revival Attempts)
The Mega Man series, a 'Question Mark' in Capcom's portfolio, faces an uncertain future. Recent revivals like "Mega Man 11" in 2018 showed promise but didn't reach the heights of previous entries. Sales data indicates moderate success, with "Mega Man 11" selling over 1 million units worldwide by early 2024. The franchise's comeback hinges on future releases.
- Mixed reception of new titles and collections.
- "Mega Man 11" sales: Over 1 million units by 2024.
- Franchise potential dependent on future quality.
- Uncertainty in market performance.
Deep Down (Cancelled)
Deep Down, a cancelled online RPG by Capcom, perfectly fits the 'Question Mark' category in the BCG Matrix. Initially, it sparked considerable excitement within the gaming community. However, its eventual cancellation transformed it into a project with unrealized potential and uncertain future impact. The game's fate reflects the inherent risks in the game development industry.
- Initial announcements of Deep Down occurred in 2013, generating significant anticipation.
- Capcom officially cancelled the project in 2020 after years of development.
- The cancellation left a void, as the game was expected to offer a unique multiplayer experience.
- The 'Question Mark' status highlights the uncertainty surrounding the game's potential market value.
Gaming's Volatile Quadrant: Risks and Uncertainties?
Question Mark titles, like Kunitsu-Gami and Pragmata, face uncertain market performance, and this status highlights inherent risks. Sales data for "Mega Man 11" showed moderate success, with over 1 million units sold by early 2024, yet the franchise's future is uncertain.
Exoprimal's mixed reception and sales, approximately 1 million units, further emphasize the volatility of this quadrant. Deep Down's cancellation showcases unrealized potential.
| Game | Status | Sales/Performance |
|---|---|---|
| Kunitsu-Gami | New IP | Unproven |
| Pragmata | Delayed | Uncertain |
| Exoprimal | Launched 2023 | ~1M units |
| Mega Man Series | Revivals | Moderate, ~1M units |
BCG Matrix Data Sources
The Capcom BCG Matrix uses reliable sources such as financial reports, market analysis, and industry studies for its assessments.
